CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 4 Open-market buy Director bought 3,803 shares at an average $6.50 ($24,719)
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 1,205,837 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- S-1 Offering Registration Statement
- 4 Open-market buy Director bought 7,500 shares at $6.50 ($48,750)
- 8-K Event Material agreement
- 4 Open-market buy Director bought 2,604 shares at $6.50 ($16,924)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
Page 32 of 53 · 1,057 filings